Park JS - Search Results

1

Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women.

Kim SC, Song YS, Kim YT, Kim YT, Ryu KS, Gunapalaiah B, Bi D, Bock HL, Park JS. Kim SC, et al. Among authors: park js. J Gynecol Oncol. 2011 Jun 30;22(2):67-75. doi: 10.3802/jgo.2011.22.2.67. J Gynecol Oncol. 2011. PMID: 21860731 Free PMC article.

2

Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women.

Kim YB, Song YS, Jeon YT, Park JS, Um SJ, Kim JW, Park NH, Kang SB, Lee HP. Kim YB, et al. Among authors: park nh, park js. Oncol Rep. 2005 Aug;14(2):459-64. Oncol Rep. 2005. PMID: 16012730

3

Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis.

Bae JH, Lee SJ, Kim CJ, Hur SY, Park YG, Lee WC, Kim YT, Ng TL, Bock HL, Park JS. Bae JH, et al. Among authors: park yg, park js. J Microbiol Biotechnol. 2008 Apr;18(4):788-94. J Microbiol Biotechnol. 2008. PMID: 18467878

4

Six-year multi-centre, observational, post-marketing surveillance of the safety of the HPV-16/18 AS04-adjuvanted vaccine in women aged 10-25 years in Korea.

Kim CJ, Song R, Chen J, Tavares Da Silva F, Gopala KB, Kim JH, Bi D, Park JS. Kim CJ, et al. Among authors: park js. Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):837-842. doi: 10.1002/pds.4175. Epub 2017 Mar 7. Pharmacoepidemiol Drug Saf. 2017. PMID: 28266092 Free PMC article.

5

Human papillomavirus infection and cervical cancer prevention in Japan and Korea.

Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS. Konno R, et al. Among authors: park js. Vaccine. 2008 Aug 19;26 Suppl 12:M30-42. doi: 10.1016/j.vaccine.2008.05.006. Vaccine. 2008. PMID: 18945412

6

Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women.

Park JS, Kim YT, Lee A, Lee Y, Kim KT, Cho CH, Choi HS, Jenkins D, Pirog EC, Molijn AC, Ramakrishnan G, Chen J. Park JS, et al. Gynecol Oncol. 2013 Jul;130(1):115-20. doi: 10.1016/j.ygyno.2013.02.026. Epub 2013 Feb 26. Gynecol Oncol. 2013. PMID: 23485771

7

A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®).

Kim JH, Bae SN, Lee CW, Song MJ, Lee SJ, Yoon JH, Lee KH, Hur SY, Park TC, Park JS. Kim JH, et al. Among authors: park tc, park js. Gynecol Oncol. 2011 Aug;122(2):303-6. doi: 10.1016/j.ygyno.2011.04.026. Epub 2011 May 24. Gynecol Oncol. 2011. PMID: 21605892

8

Clinical significance of human papillomavirus genotyping.

Choi YJ, Park JS. Choi YJ, et al. Among authors: park js. J Gynecol Oncol. 2016 Mar;27(2):e21. doi: 10.3802/jgo.2016.27.e21. J Gynecol Oncol. 2016. PMID: 26768784 Free PMC article. Review.

9

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?

Sung YE, Ki EY, Lee YS, Hur SY, Lee A, Park JS. Sung YE, et al. Among authors: park js. J Gynecol Oncol. 2016 Nov;27(6):e56. doi: 10.3802/jgo.2016.27.e56. Epub 2016 Jul 1. J Gynecol Oncol. 2016. PMID: 27550402 Free PMC article.

10

Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.

Bae JH, Lee SJ, Lee A, Park YG, Bae SN, Park JS, Namkoong SE. Bae JH, et al. Among authors: park yg, park js. Gynecol Oncol. 2008 Dec;111(3):444-8. doi: 10.1016/j.ygyno.2008.07.034. Epub 2008 Oct 1. Gynecol Oncol. 2008. PMID: 18829085 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,341 results

Search Page

Filters